News
SGLT2 Inhibitors, MRA Compared for Diabetic Kidney Disease
www.renalandurologynews.com
Jul 21, · Compared with no treatment or placebo, use of SGLT2 inhibitors in combination with RAS inhibitors was significantly associated with 38% decreased odds of the composite kidney outcome, Shuo Yang ...
sorted by relevance / date